IO Biotech | 8-K: IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
IO Biotech | 8-K: Current report
IO Biotech | DEF 14A: Definitive information statements
IO Biotech | DEFA14A: Others
IO Biotech | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
IO Biotech | 8-K: IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
IO Biotech | 8-K: Current report
IO Biotech | 8-K: IO Biotech Announces 2023 Third Quarter Results
IO Biotech | S-3: Registration statement for specified transactions by certain issuers
IO Biotech | 8-K: IO Biotech Announces 2023 Second Quarter Results
IO Biotech | 8-K: Current report
IO Biotech | 8-K: Current report
IO Biotech | 8-K: Current report
IO Biotech | 8-K: Current report
IO Biotech | 8-K: IO Biotech Announces 2023 First-Quarter Results
IO Biotech | DEFA14A: Others
IO Biotech | DEF 14A: Definitive proxy statements
IO Biotech | 8-K: Current report
IO Biotech | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
IO Biotech | 8-K: IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
No Data